According to Sino Biopharmaceutical's latest financial reports the company's total assets are S$11.40 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | S$11.88 B | -4.57% |
2022-12-31 | S$12.45 B | -3.05% |
2021-12-31 | S$12.84 B | 34.14% |
2020-12-31 | S$9.57 B | 32.27% |
2019-12-31 | S$7.23 B | 25.54% |
2018-12-31 | S$5.76 B | 33.99% |
2017-12-31 | S$4.30 B | 12.33% |
2016-12-31 | S$3.83 B | 27.19% |
2015-12-31 | S$3.01 B | 24.65% |
2014-12-31 | S$2.41 B | 48.2% |
2013-12-31 | S$1.63 B | 34.09% |
2012-12-31 | S$1.21 B | 17.46% |
2011-12-31 | S$1.03 B | 10.96% |
2010-12-31 | S$0.93 B | 36.91% |
2009-12-31 | S$0.68 B | 12.87% |
2008-12-31 | S$0.60 B | 26.54% |
2007-12-31 | S$0.47 B | 9.37% |
2006-12-31 | S$0.43 B | -5.1% |
2005-12-31 | S$0.45 B | 130.04% |
2004-12-31 | S$0.19 B | 23.92% |
2003-12-31 | S$0.16 B | 22.05% |
2002-12-31 | S$0.13 B | 28.54% |
2001-12-31 | S$0.10 B |